The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical disposables market size reached US$ 358.41 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 628.04 Billion by 2027, exhibiting a growth rate (CAGR) of 9.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Medical disposables refer to devices, apparatus, and consumables that are intended for use for a brief period of time to render quality patient care in the healthcare industry. Cross-contamination between doctors and caregivers, as well as between doctors and patients, can be prevented with the use of these devices during medical examinations, surgical procedures, and treatments. Using disposable medical supplies in medical settings is an essential component of infection control strategies as it simplifies employee tasks and reduces healthcare costs. Single-use products offer enhanced convenience over their traditional counterparts, thereby saving a considerable amount of time and money for sterilizing. Gloves, face masks, blood bags, and needles are some of the most commonly used medical disposables.
The market is primarily driven by the increasing incidences of hospital-acquired infections (HAIs) and surgical-site infections across the globe. This can be attributed to the rising number of surgical procedures requiring longer hospital admissions. In addition to this, a considerable rise in the prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is also acting as a significant growth-inducing factor for the market. The market is also propelled by a paradigm shift towards single-use and short-term use medical supplies due to the increasing health and hygiene consciousness among the masses. Moreover, the augmenting adoption of bioplastics due to the rising environmental concerns are further creating a positive outlook for the market. Furthermore, the expanding geriatric population that is susceptible to developing various chronic illnesses is positively impacting the market growth. Some of the other factors contributing to the market include rapid improvements in healthcare infrastructure, rising government investments, continual product innovations, and extensive research and development (R&D) activities conducted by key players.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical disposables market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, raw material and end use.
Breakup by Product:
Breakup by Raw Material:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Abbott Laboratories, AMMEX Corporation, Ansell Ltd., B Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Medline Industries LP, Medtronic plc, Narang Medical Limited, Smith & Nephew plc and Terumo Cardiovascular Systems Corporation (Terumo Medical Corporation).
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Raw Material, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3M Company, Abbott Laboratories, AMMEX Corporation, Ansell Ltd., B Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Medline Industries LP, Medtronic plc, Narang Medical Limited, Smith & Nephew plc and Terumo Cardiovascular Systems Corporation (Terumo Medical Corporation).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at